30 Nov Stock Market Update: Market slips lower in early trade

Sensex nifty down Key benchmark indices slipped in the early morning trade on Thursday due to market movements seemed to have turned negative ahead of India’s GDP growth data which is due today later evening. The stocks of State Bank of India, Kotak Mahindra Bank, Axis Bank, Reliance Industries, Bharti Airtel traded in the red in early trade. 

At 10.35 am, the BSE Sensex traded lower by 252.09 points at 33,350.67, while the NSE Nifty 50 fell 76.50 points to 10,284.80.

Jewellery stocks such as Tara Jewels fell 8.3%, Gitanjali Gems fell 2.4%, PC Jeweller declined 1.8%, among others; while stocks of Healthcare Global rose 5 percent.

Shares of Bajaj Auto and Dr Reddy’s Laboratories were the major gainers on Sensex, rising up over 1 percent while State Bank of India, Axis Bank, Kotak Mahindra Bank, Reliance (RIL) Adani Ports, lost up to 1.7 percent.

Most of the Asian shares also sunk in the early morning session today after the US technology barometer index lost nearly 1 percent on Wednesday.

The rupee goes down 24 paise at 64.55 versus the US dollar in the morning ahead of the Sept quarter GDP data.

Stock Market News- Stocks to Watch out on 22 November 2017

sensex up Key benchmark indices edged higher in early trade on Wednesday, with indices extending fresh gains tracking steadiness in Asian stocks. The stocks of Adani Ports, Mahindra and Mahindra, Bajaj Auto, HDFC rose, while the shares of Dr. Reddy’s and Axis Bank fell in early hours. At 10.35 am, the BSE Sensex traded higher by 38.28 points to 33,514.63, while the NSE Nifty 50 rose 0.65 points to 10,327.55.

Stocks to watch out today: Steel Authority of India’s (SAIL) stock will be watched out as the company is likely to have JV for 1.5 million ton steel plant for production of auto-grade steel with Arcelor Mittal.

Telecom sector stocks will be in limelight as the Telecom Regulator has put forward relaxing spectrum holding limits.

Shares of Reliance Industries Limited is on watch after the global investment banking company Goldman Sachs raised their target price by 26% to Rs 1,205. RIL shares rose by 2% to Rs.939.65, on Tuesday’s closing.

Ajanta Pharma announced that it has got the USFDA approval for the bioequivalent generic version of Kapvay tablets and the same has been launched in US market through its wholly owned subsidiary, Ajanta Pharma USA Inc.

Bank of Baroda has announced that it has approved the proposal of raising additional equity capital aggregating upto Rs 6000 crore by way of rights issue or QIP, depending on applicable statutory approvals.